Elsevier

Neuroscience Letters

Volume 246, Issue 1, 17 April 1998, Pages 41-44
Neuroscience Letters

MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain

https://doi.org/10.1016/S0304-3940(98)00221-3Get rights and content

Abstract

Focal cerebral ischemia in rats produces elevated levels of tumor necrosis factor (TNF)α in the ischemic brain region. To better understand the modulation of TNF during brain ischemia processes we carried out studies in a model of permanent middle cerebral artery occlusion (MCAo) in the rat. In non-treated ischemic animals, the maximum expression of TNF was observed at 12 h (246.1±33 U/g) in the ischemic cortex and declined reaching near zero levels 24 h after MCAo. Given 10 min after MCAo, MK 801 (3 mg/kg, i.p.), a non-competitive NMDA receptor antagonist, exerted significant neuroprotection as measured by 47% reduction of total volume of infarction (P<0.01 vs. ischemic-control). At the high dose of 3 mg/kg i.p., dexamethasone (DEX), which is known to reduce brain edema, decreased infarct size by 50% (P<0.01 vs. ischemic-control). Both MK 801 and DEX reduced TNF production in the ipsilateral cortex of ischemic animals by 61 and 73%, respectively (P<0.01 vs. ischemic-control). The data indicate that TNF levels increase after brain infarction, whereas they are reduced by neuroprotective agents, such as MK 801 and DEX, which act on different cellular levels.

References (19)

There are more references available in the full text version of this article.

Cited by (71)

  • Time dependent neuroprotection of dexamethasone in experimental focal cerebral ischemia: The involvement of NF-κB pathways

    2018, Brain Research
    Citation Excerpt :

    For example, de Courten-Myers et al. (1994) indicate that administering methylprednisolone at high doses early (starting 30 min after occlusion) after onset of ischemia significantly reduces tissue injury in cats that survive 4 days of temporary middle cerebral artery occlusion. In the study of Bertorelli et al. (1998), dexamethasone was given 10 min after MCAO, and at the high dose of 3 mg/kg i.p., reduced TNF production in the ipsilateral cortex and reduce brain edema, decreased infarct size by 50%. Corticosteroids therapy in most of the study reported negative results were later than two hours (de la Torre and Surgeon, 1976; Koide et al., 1986; Norris and Hachinski, 1986).

  • Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors

    2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • Context-Dependent GluN2B-Selective Inhibitors of NMDA Receptor Function Are Neuroprotective with Minimal Side Effects

    2015, Neuron
    Citation Excerpt :

    Of these four behaviors (locomotor activity, rotorod, PCP discrimination, and lever pressing), we identified only one in which 93-31 caused significant effects at doses of 30 mg/kg or higher. From the ED50 for neuroprotection (<1 mg/kg) we calculate a TR for neuroprotection in rodents following IP administration of >30 for the pH-sensitive 93-31 GluN2B inhibitor, a value considerably higher than that estimated for neuroprotection in the literature for ifenprodil and dizolcilpine (TR ≤ 1; Hatfield et al., 1992; Bertorelli et al., 1998; Dawson et al., 2001; Xiao et al., 2004) and CP-101,606 (TR ∼4; Yang et al., 2003, Nicholson et al., 2007). Two important findings emerge from this study.

  • Dexamethasone-induced neuroprotection in hypoxic-ischemic brain injury in newborn rats is partly mediated via Akt activation

    2014, Brain Research
    Citation Excerpt :

    So, we suggest that corticosteroids may induce pharmacological preconditioning. Pretreatment with Dex is neuroprotective in neonatal rats (Barks et al., 1991; Dardzinski et al., 2000; Felszeghy et al., 2004; Tuor et al., 1993) and in the adult rat and mice (Bertorelli et al., 1998; Limbourg et al., 2002). Pretreatment with Dex has shown very strong neuroprotection, from 90% to 100% of brain damage in the present study and in other reports (Feng et al., 2011; Liu et al., 1995; Tuor and Del Bigio, 1996).

  • Dexamethasone exacerbates cerebral edema and brain injury following lithium-pilocarpine induced status epilepticus

    2014, Neurobiology of Disease
    Citation Excerpt :

    Following status epilepticus, rats were randomly assigned to one of two groups: SE-DEX10 rats (n = 13) received dexamethasone sodium phosphate (10 mg/kg, equivalent to 7.6 mg/kg dexamethasone) immediately following status epilepticus and at 24 h (10 mg/kg) following SE. This dose is comparable to doses that have shown or attempted to demonstrate efficacy in other rat models of brain edema (Altman et al., 1984; Bertorelli et al., 1998; Mima and Shigeno, 2000; Shapira et al., 1988; Tran et al., 2010). SE rats (n = 15) received saline injections in place of dexamethasone.

View all citing articles on Scopus
View full text